Sherbrooke Park Advisers’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$73.6K Buy
+10,952
New +$82.1K 0.19% 145
2025
Q3
Sell
-16,461
Closed -$116K 619
2025
Q2
$116K Sell
16,461
-13,363
-45% -$89.9K 0.05% 445
2025
Q1
$213K Buy
29,824
+2,141
+8% +$20.2K 0.1% 408
2024
Q4
$254K Sell
27,683
-31,386
-53% -$294K 0.08% 476
2024
Q3
$573K Buy
59,069
+45,042
+321% +$473K 0.13% 253
2024
Q2
$114K Buy
+14,027
New +$109K 0.02% 825

Other funds holding INGN

Sherbrooke Park Advisers's INGN Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in Inogen (INGN) in Q4 2025: 10,952 shares worth $73.6K. The stake represents 0.19% of the portfolio and ranks #145 among its holdings. This is a return to the name: Sherbrooke Park Advisers previously reported a position in INGN as recently as Q2 2025.

Sherbrooke Park Advisers first reported a position in INGN in Q2 2024 and has held it in 6 quarters since. The position peaked at $573K in Q3 2024. 133 funds tracked by Wall St. Rank hold INGN as of Q4 2025.

  • Sherbrooke Park Advisers held 10,952 shares of Inogen worth $73.6K as of Q4 2025.
  • Inogen was a new Sherbrooke Park Advisers position in Q4 2025.
  • Inogen made up 0.19% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #145 holding.
  • Sherbrooke Park Advisers first reported a position in Inogen in Q2 2024 and has held it in 6 quarters since.
  • Sherbrooke Park Advisers's Inogen position peaked at $573K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held Inogen as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.